Research and Markets: Global Cancer Monoclonal Antibodies Pipeline Analysis Business Wire (press release) In the past few years monoclonal antibodies have emerged as a therapeutic modality for cancer. These monoclonal antibodies are designed to selectively target cancer cells and extract various responses, thus indirectly protecting the non cancerous cells. |
